This is a re-activation of antibiotic drug discovery research and related international projects latest plan – for large pharmaceutical companies in the past is a popular business. Due to the shorter course of antibiotic treatment, and doctors want to retain respond to future emergencies factor most effective drugs, pharmaceutical companies are so difficult to profit. Looking for new targets of antibiotics, the “grow fruit has been low-wise.” President of a pharmaceutical company and a visiting scholar at Harvard Medical School, Gail Cassell said.
1 2
Leave a Reply